PeptideDB

KRAS inhibitor-3

CAS: 900897-56-5 F: C25H27N5O W: 413.51

KRAS inhibitor-3 is an inhibitor of KRAS inhibitor. KRAS inhibitor-3 binds to WT and oncogenic KRAS mutants with high af
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity KRAS inhibitor-3 is an inhibitor of KRAS inhibitor. KRAS inhibitor-3 binds to WT and oncogenic KRAS mutants with high affinity (KD: 0.28 μM for KRAS WT, 0.63 μM for KRAS G12C, 0.37 μM for KRAS G12D, 0.74 μM for KRAS Q61H). KRAS inhibitor-3 also disrupts interaction of KRAS with Raf[1].
Invitro KRAS inhibitor-3 (0-5 μM) 降低稳定表达 KRASG12D 的 BHK 细胞中的 p-ERK 水平[1]。KRAS inhibitor-3 (1 μM,2 小时) 破坏 KRAS 与 Raf 的相互作用[1]。KRAS inhibitor-3 (0-5 μM) 降低表达 KRASG12D 和 KRASG12V 的 BHK 细胞中的 p-ERK 和 p-cRaf 水平[1]。 Western Blot Analysis[1] Cell Line:
Name KRAS inhibitor-3
CAS 900897-56-5
Formula C25H27N5O
Molar Mass 413.51
Appearance Solid
Transport Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Reference [1]. McCarthy MJ, et al. Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding. ACS Omega. 2019 Feb 28;4(2):2921-2930.